DOI:
10.1055/s-00000069
Seminars in Liver Disease
LinksClose Window
References
Brown ZJ, Yu SJ, Heinrich B. et al.
Indoleamine 2,3-dioxygenase provides adaptive resistance to immune checkpoint inhibitors in hepatocellular carcinoma.
Cancer Immunol Immunother 2018;
67 (08) 1305-1315
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.